Non-interventional Study to Investigate the Effectiveness, Safety and Utilization of Vismodegib on Locally Advanced and Metastatic Basal Cell Carcinoma Under Real World Conditions
Phase of Trial: Phase IV
Latest Information Update: 10 Apr 2017
At a glance
- Drugs Vismodegib (Primary)
- Indications Basal cell cancer
- Focus Therapeutic Use
- Acronyms JONAS
- 01 Apr 2017 Planned End Date changed from 1 Apr 2020 to 1 Apr 2021.
- 01 Apr 2017 Planned primary completion date changed from 1 Apr 2020 to 1 Apr 2021.
- 02 Jul 2016 Status changed from not yet recruiting to recruiting.